Cargando…
Escape from planned obsolescence: Hepatitis C, the cirrhotic liver, and clonal expansions
Eliminating the burden of disease caused by hepatitis C virus infection is proving difficult, despite the availability of curative drug treatments. Progress will require innovations in healthcare delivery and a deeper understanding of how the liver and other vital organs survive damage caused by chr...
Autor principal: | Branch, Andrea D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062522/ https://www.ncbi.nlm.nih.gov/pubmed/33002101 http://dx.doi.org/10.1084/jem.20191070 |
Ejemplares similares
-
Adoptive cell therapy: Living drugs against cancer
por: Laskowski, Tamara, et al.
Publicado: (2020) -
SARS-CoV-2 spike therapeutic antibodies in the age of variants
por: Baum, Alina, et al.
Publicado: (2021) -
Surmounting structural barriers to tackle endemic infectious diseases
por: Calderón, Felix, et al.
Publicado: (2021) -
Advances toward structure-based drug discovery for inflammasome targets
por: Wang, Li, et al.
Publicado: (2021) -
Drug development challenges in nontuberculous mycobacterial lung disease: TB to the rescue
por: Dartois, Véronique, et al.
Publicado: (2022)